Management of pancreatic cancer liver metastasis through investigating the mechanism of formation and remodeling its microenvironment.
Project/Area Number |
26462063
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Kyushu University |
Principal Investigator |
FUJITA Hayato 九州大学, 医学研究院, 助教 (40611281)
|
Co-Investigator(Kenkyū-buntansha) |
前山 良 九州大学, 医学研究院, 共同研究員 (10611668)
田中 雅夫 九州大学, 医学研究院, 教授 (30163570)
江上 拓哉 九州大学, 医学研究院, 共同研究員 (40507787)
真鍋 達也 九州大学, 大学病院, 講師 (60546464)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 膵癌 / 肝転移 / 間質リモデリング / 線維芽細胞 |
Outline of Final Research Achievements |
The aim of this study is to develop a new therapeutic strategy targeting the specific cell population and its molecular mechanism. Microarray analysis revealed the lower miR-5100 expression in the highly metastatic pancreatic cancer cell, and we found the fact that the expression of PODXL, a target gene of miR-5100, correlates with the patients’ survival and the frequency of liver metastasis. PODXL knock down in the pancreatic cancer cell decreased its aggressive phenotype, suggesting that PODXL is a potential therapeutic target to inhibit liver metastasis. Further, observation of the liver and lung metastasis mouse model revealed the fact that liver metastases contains significantly more α-SMA positive stromal cells than lung metastases.
|
Report
(4 results)
Research Products
(13 results)
-
[Journal Article] Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination.2017
Author(s)
Abe T, Ohuchida K, Koikawa K, Endo S, Okumura T, Sada M, Horioka K, Zheng B, Moriyama T, Nakata K, Miyasaka Y, Manabe T, Ohtsuka T, Nagai E, Mizumoto K, Hashizume M, Nakamura M.
-
Journal Title
Int J Oncol
Volume: 50
Issue: 2
Pages: 457-467
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
[Journal Article] (The) Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model2016
Author(s)
Yoshida M, Miyasaka Y, Ohuchida Kenoki, Okumura T, Zheng B, Torata N, Fujita H, Nabae T, Manabe T, Shimamoto M, Ohtsuka T, Mizumoto K, Nakamura M
-
Journal Title
Cancer Sci
Volume: 107
Issue: 10
Pages: 1443-1452
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
[Journal Article] Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer2016
Author(s)
Horioka K, Ohuchida K, Sada M, Zheng B, Moriyama T, Fujita H, Manabe T, Ohtsuka T, Shimamoto M, Miyazaki T, Mizumoto K, Oda Y, Nakamura M.
-
Journal Title
Int J Oncol
Volume: 48
Issue: 4
Pages: 1499-1508
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] Peritoneal myofibroblasts at metastatic foci promote dissemination of pancreatic cancer.2014
Author(s)
Akagawa S, Ohuchida K, Torata N, Hattori M, Eguchi D, Fujiwara K, Kozono S, Cui L, Ikenaga N, Ohtsuka T, Oishima S, Mizumoto K, Oda Y, Tanaka M
-
Journal Title
Int J Oncol
Volume: 45
Issue: 1
Pages: 113-120
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
[Journal Article] CD166/ALCAM expression is characteristic of tumorigenicity and invasive and migratory activities of pancreatic cancer cells.2014
Author(s)
Fujiwara K, Ohuchida K, Sada M, Horioka K, Ulrich CD 3rd, Shindo K, Ohtsuka T, Takahata S, Mizumoto K, Oda Y, Tanaka M.
-
Journal Title
PLoS One
Volume: 9
Issue: 9
Pages: 1-11
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-